USPTO trademark

MENTARI

Under examinationUSPTOWord markClass 5

"MENTARI" is a word mark owned by Mentari Therapeutics, Inc., filed at the USPTO on August 26, 2026. It is under examination and covers class 5 (Pharmaceuticals).

Get this data via the API
Official USPTO record
MENTARI trademark as filed
As filed with the USPTO
Status
Under examination
Since August 26, 2026
Filed
August 26, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50072915
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns MENTARI

The owner and representative on file with the office.

Owner

Mentari Therapeutics, Inc.

Waltham, United States

Representative

Austin D. Padgett, Esq.

Goods and services

What the mark covers

The products and services MENTARI is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the prevention and treatment of migraine, chronic migraine, episodic migraine, and migraine-associated disorders; biologics for the prevention and treatment of migraine; biopharmaceutical preparations for the prevention and treatment of migraine and migraine-associated disorders; biological preparations for therapeutic use in the prevention and treatment of migraine; bispecific antibodies for therapeutic use, namely for the prevention of migraine; pharmaceutical preparations comprising anti-PACAP antibodies for the prevention and treatment of migraine; pharmaceutical preparations comprising anti-CGRP antibodies for the prevention and treatment of migraine; pharmaceutical preparations comprising bispecific antibodies targeting both CGRP and PACAP for therapeutic use in the prevention of migraine; pharmaceutical preparations for the treatment of neurological disorders; biologic preparations for the treatment of neurological disorders; pharmaceutical preparations for subcutaneous injection for the prevention of migraine; injectable pharmaceutical preparations in the field of migraine prevention; pharmaceutical preparations for self-administration via autoinjector for the prevention of migraine; pharmaceutical preparations for quarterly subcutaneous administration for the prevention of migraine; monospecific antibodies for therapeutic use, namely for the prevention of migraine

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. New application office supplied data entered
  3. New application entered
FAQ

About MENTARI

Who owns the trademark "MENTARI"?

The USPTO trademark "MENTARI" (application 50072915) is owned by Mentari Therapeutics, Inc.

What is the status of "MENTARI"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull MENTARI and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a0429f-6a65-769e-918d-892c9c65bcce
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a0429f-6a65-769e-918d-892c9c65bcce",
  "object": "trademark",
  "mark_text": "MENTARI",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50072915",
  "filing_date": "2026-08-26",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Mentari Therapeutics, Inc.",
      "entity_id": null
    }
  ]
}